How I Do It: The Optilume drug-coated balloon for urethral strictures.

Urethral stricture disease can be difficult to treat and stricture recurrence is common. The management of stricture disease has evolved and urethroplasty can achieve a high rate of lasting urethral patency. Nevertheless, endoscopic treatments still seem to have sub-optimal outcomes with high stricture recurrence rates. The Optilume drug-coated balloon represents a step forward in the endoscopic management of urethral strictures. The drug-coated balloon may offer an intermediate step prior to repeated dilations, urethrostomies, or urethroplasty. This treatment modality is a promising alternative to current endoscopic management and an option for patients that are poor surgical candidates or decline urethroplasty.

[1]  S. Elliott,et al.  A drug-coated balloon treatment for urethral stricture disease: Two-year results from the ROBUST I study. , 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[2]  S. Elliott,et al.  A drug-coated balloon treatment for urethral stricture disease: Interim results from the ROBUST I study. , 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[3]  R. Santucci,et al.  Male Urethral Stricture: American Urological Association Guideline , 2017, The Journal of urology.

[4]  Jinsung Park,et al.  The effects of hyaluronic acid and carboxymethylcellulose in preventing recurrence of urethral stricture after endoscopic internal urethrotomy: a multicenter, randomized controlled, single-blinded study. , 2013, Journal of endourology.

[5]  R. Pickard,et al.  Long-term effect of urethral dilatation and internal urethrotomy for urethral strictures , 2012, Current opinion in urology.

[6]  S. Mohammadi,et al.  Triamcinolone injection following internal urethrotomy for treatment of urethral stricture. , 2011, Urology journal.

[7]  K. Min,et al.  Early Experience with Hyaluronic Acid Instillation to Assist with Visual Internal Urethrotomy for Urethral Stricture , 2010, Korean journal of urology.

[8]  R. Santucci,et al.  Urethrotomy has a much lower success rate than previously reported. , 2010, The Journal of urology.

[9]  G. Jordan,et al.  Management of distal anterior urethral strictures , 2009, Nature Reviews Urology.

[10]  P. Black,et al.  Meshed unexpanded split-thickness skin grafting for reconstruction of penile skin loss. , 2004, The Journal of urology.

[11]  D. Nicol,et al.  Repeat urethrotomy and dilation for the treatment of urethral stricture are neither clinically effective nor cost-effective. , 2004, The Journal of urology.

[12]  D. Johnson,et al.  Assessment of a new transurethral balloon dilation catheter in the treatment of urethral stricture disease. , 2000, Urology.

[13]  C. Heyns,et al.  Internal urethrotomy versus dilation as treatment for male urethral strictures: a prospective, randomized comparison. , 1997, The Journal of urology.